Brind.

Mira and Frontiers reported market opportunities in North America and accepted a peer-reviewed manuscript.

1 report, 1 independent Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Mira and Frontiers reported market opportunities in North America and accepted a peer-reviewed manuscript.

Who's involved

What this event is mainly about
MiraFrontiers

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ACCESS NewswireMIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabal